FLT1 and neoplasm: About 85%, 92%, and 87% of patients with a tumor size ≥5 cm had VEGFR-1-positive, VEGFR-2-positive, and VEGFR-3-positive tumor tissues compared with 64%, 73%, and 70% of patients with a tumor size <5 cm.